Pharmaceuticals

  • All Post
  • Business
  • Consumer
  • Health
  • In-Motion
  • Infrastructure
  • Manufacturing
  • Sustainability
  • Technology
    •   Back
    • Academia / R&D
    • Testing / NDT
    • Automation
    • Electronics / Data Centres
    • Training
    • Industry 4 & SMART
    •   Back
    • Government & Legislation
    • Awards & Events
    • Accreditation
    • Appointments & Personnel
    • Legal & Finance
    • Warehouse & Logistics
    •   Back
    • Software
    • Tooling
    • Composites / Plastics
    • Additive
    • Chemical
    • Sub-Contract
    •   Back
    • Military & Defence
    • Space
    • Rail
    • Aerospace
    • Marine
    • Automotive
    •   Back
    • Civil & Structural Engineering
    • Nuclear
    • Construction Products
    • Oil & Gas
    • Fabrication
    • Mining
    •   Back
    • Health & Safety
    • Consumer Technology
    • Supplies
    • Medical Technology
    • Pharmaceuticals
    • Public Sector
    •   Back
    • Food & Drink
    • Textiles & Clothing
    • Sports & Leisure
    • Furniture & Furnishings
    • Electricals
    • Packaging & Production
    •   Back
    • Waste Management
    • Environmental
    • EV & Fuel Cells
    • Energy Generation
    • Water Management
    • Recycling

January 5, 2017

Scientists from the Tomsk Polytechnic University’s Laboratory of Novel Dosage are developing a technology to control mesenchymal stem cells of patients. The technology will allow treating cancer more effective. To fight cancer cells the scientists suggest using the patient’s own...

July 4, 2016

Manchester-based engineering company, Haden Freeman, has signed a cooperation deal with Dutch firm Tebodin B.V. as it expands further into the multibillion-pound pharmaceutical market. The deal will mean that Haden Freeman and Tebodin B.V. (which is part of Bilfinger, an...

Featured MEM Health

Subscribe to MEM Newsletters!